Aligos Therapeutics
ALGS
ALGS
34 hedge funds and large institutions have $64.5M invested in Aligos Therapeutics in 2024 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
8.31% less ownership
Funds ownership: 55.11% → 46.8% (-8.3%)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.23M | |
| 2 | +$2.75M | |
| 3 | +$2.56M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.31M |
| 5 |
AAS
Avantax Advisory Services
Dallas,
Texas
|
+$1.22M |
Top Sellers
| 1 | -$2.73M | |
| 2 | -$1.08M | |
| 3 | -$796K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$263K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$262K |